NEW YORK STATE COMMON RETIREMENT FUND - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$48
-23.8%
13,756
+1.9%
0.00%
Q2 2023$630.0%13,499
-0.5%
0.00%
Q1 2023$63
-75.2%
13,568
-56.8%
0.00%
Q4 2022$254
-99.8%
31,393
+64.2%
0.00%
Q3 2022$106,000
+7.1%
19,122
+0.6%
0.00%
Q2 2022$99,000
-61.5%
19,015
-39.2%
0.00%
Q1 2022$257,000
-44.7%
31,2780.0%0.00%
Q4 2021$465,000
-21.5%
31,278
-0.2%
0.00%
-100.0%
Q3 2021$592,000
-15.1%
31,353
-16.3%
0.00%0.0%
Q2 2021$697,000
+30.3%
37,467
+59.4%
0.00%0.0%
Q1 2021$535,000
+4.9%
23,5000.0%0.00%0.0%
Q4 2020$510,000
+359.5%
23,500
+113.6%
0.00%
Q3 2020$111,000
+30.6%
11,0000.0%0.00%
Q2 2020$85,000
-24.1%
11,0000.0%0.00%
Q1 2020$112,000
-7.4%
11,0000.0%0.00%
Q4 2019$121,000
+21.0%
11,0000.0%0.00%
Q3 2019$100,000
-20.0%
11,0000.0%0.00%
Q2 2019$125,000
+861.5%
11,000
+900.0%
0.00%
Q1 2019$13,0001,1000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders